Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Hartmann

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative studyK Oechsle, F Honecker, T Cheng, et al.
Zentralblatt Fur Chirurgie|October 17, 2008
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]I Königsrainer, P Aschoff, D Zieker, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma GroupP Reichardt, O S Nielsen, S Bauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinionK Potthoff, R Hofheinz, J C Hassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
British Journal of Cancer|January 10, 2008
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialO Nehls, H Oettle, J T Hartmann, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative studyK Oechsle, F Honecker, T Cheng, et al.
Zentralblatt Fur Chirurgie|October 17, 2008
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]I Königsrainer, P Aschoff, D Zieker, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma GroupP Reichardt, O S Nielsen, S Bauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinionK Potthoff, R Hofheinz, J C Hassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
British Journal of Cancer|January 10, 2008
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialO Nehls, H Oettle, J T Hartmann, et al.
Pageof 12